1. Desai, K, Gupta, SB, Dubberke, ER, Prabhu, VS, Browne, C, Mast, TC. Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach. BMC Infect Dis 2016;16:303.
2. Bartlett, JG. Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002;346:334–339.
3. Bartlett, JG, Gerding, DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008;46(Suppl 1):S12–S18.
4. Katz, DA, Lynch, ME, Littenberg, B. Clinical prediction rules to optimize cytotoxin testing for Clostridium difficile in hospitalized patients with diarrhea. Am J Med 1996;100:487–495.
5. Gerding, DN, Brazier, JS. Optimal methods for identifying Clostridium difficile infections. Clin Infect Dis 1993;16(Suppl 4):S439–S442.
6. Brecher, SM, Novak-Weekley, SM, Nagy, E. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis 2013;57:1175–1181.
7. Carey, RG, Lloyd, RC. Measuring Quality Improvement in Healthcare. Milwaukee: Quality Press; 2001.
8. Bunnell, KL, Danziger, LH, Johnson, S. Economic barriers in the treatment of Clostridium difficile infection with oral vancomycin. Open Forum Infect Dis 2017;4:ofx078.
9. Fang, FC, Polage, CR, Wilcox, MH. Point-counterpoint: What is the optimal approach for detection of Clostridium difficile infection? J Clin Microbiol 2017;55:670–680.
10. Burnham, CA, Carroll, KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev 2013;26:604–630.